SAMSUNG BIOLOGICSSAMSUNG BIOLOGICSSAMSUNG BIOLOGICS

SAMSUNG BIOLOGICS

No trades
See on Supercharts
Market capitalization
‪55.23 T‬KRW
‪857.69 B‬KRW
‪3.69 T‬KRW
‪18.31 M‬
Beta (1Y)
0.71

About SAMSUNG BIOLOGICS

CEO
John Chongbo Rim
Headquarters
Inchon
Founded
2011
ISIN
KR7207940008
FIGI
BBG00DLBLKV1
SAMSUNG BIOLOGICS Co., Ltd. engages in the provision of contract manufacturing organization services for pharmaceutical products. The company was founded on April 22, 2011 and is headquartered in Incheon, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where 207940 is featured.

Frequently Asked Questions

The current price of 207940 is 790000 KRW — it has increased by 1.80% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange SAMSUNG BIOLOGICS stocks are traded under the ticker 207940.
SAMSUNG BIOLOGICS is going to release the next earnings report on Apr 23, 2024. Keep track of upcoming events with our Earnings Calendar.
207940 stock is 2.70% volatile and has beta coefficient of 0.71. Check out the list of the most volatile stocks — is SAMSUNG BIOLOGICS there?
One year price forecast for SAMSUNG BIOLOGICS has a max estimate of 1250000 KRW and a min estimate of 780000 KRW.
207940 earnings for the last quarter are ‪3.38 K‬ KRW whereas the estimation was ‪3.32 K‬ KRW which accounts for 1.69% surprise. Estimated earnings for the next quarter are ‪3.11 K‬ KRW. See more details about SAMSUNG BIOLOGICS earnings.
SAMSUNG BIOLOGICS revenue for the last quarter amounts to ‪1.03 T‬ KRW despite the estimated figure of ‪976.51 B‬ KRW. In the next quarter revenue is expected to reach ‪1.06 T‬ KRW.
Yes, you can track SAMSUNG BIOLOGICS financials in yearly and quarterly reports right on TradingView.
207940 stock has fallen by 0.75% compared to the previous week, the month change is a 8.14% fall, over the last year SAMSUNG BIOLOGICS has showed a 0.75% decrease.
207940 net income for the last quarter is ‪290.68 B‬ KRW, while the quarter before that showed ‪240.37 B‬ KRW of net income which accounts for 20.93% change. Track more SAMSUNG BIOLOGICS financial stats to get the full picture.
Today SAMSUNG BIOLOGICS has the market capitalization of ‪55.23 T‬, it has decreased by 0.12% over the last week.
No, 207940 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 207940 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SAMSUNG BIOLOGICS stock right from TradingView charts — choose your broker and connect to your account.
207940 reached its all-time high on Aug 18, 2021 with the price of 1036000 KRW, and its all-time low was 124000 KRW and was reached on Nov 10, 2016.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SAMSUNG BIOLOGICS technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SAMSUNG BIOLOGICS stock shows the buy signal. See more of SAMSUNG BIOLOGICS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SAMSUNG BIOLOGICS future price: according to them, 207940 price has a max estimate of 1250000.00 KRW and a min estimate of 780000.00 KRW. Read a more detailed SAMSUNG BIOLOGICS forecast: see what analysts think of SAMSUNG BIOLOGICS and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SAMSUNG BIOLOGICS EBITDA is ‪1.60 T‬ KRW, and current EBITDA margin is 43.40%. See more stats in SAMSUNG BIOLOGICS financial statements.